Hasil Filter

1977

Total database: 17430
Struktur (SMILES)
1074 (54.3%)
Target
1046 (52.9%)
Genomik
39 (2.0%)
Referensi
1977 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (1977)

Halaman 38 / 40
TRO40303 DB16031
small molecule | CAS: 14291-24-8

TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction).

Kategori:
AminesFused-Ring CompoundsHydroxylamines +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trolamine Approved DB13747
small molecule | CAS: 102-71-6

Trolamine, which is also referred to as triethanolamine (TEA), is a tertiary amine and a triol. It is a bifunctional compound that exhibits both properties of alcohols and amines. Trolamine contains small amounts of diethanolamine and ethanolamine and may als…

Kategori:
AlcoholsAminesAmino Alcohols +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trolamine salicylate Approved DB11079
small molecule | CAS: 2174-16-5

Trolamine salicylate is an organic compound or a salt formed between triethanolamine and salicylic acid. Triethanolamine neutralizes the acidity of the salicylic acid. It is a topical analgesic used for temporary relief of minor pain associated with arthritis…

Kategori:
Acids, CarbocyclicAgents causing hyperkalemiaAnti-Inflammatory Agents +11
Target Protein:
Prostaglandin G/H synthase 1Prostaglandin G/H synthase 2
Waktu Paruh-
Vol. DistribusiTopical administrat…
Klirens-
Genetik -
Tropifexor DB16343
small molecule | CAS: 1383816-29-2

Tropifexor is under investigation in clinical trial NCT02516605 (A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients).

Kategori:
Heterocyclic Compounds, Fused-RingThiazoles
Target Protein:
Bile acid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Troriluzole DB15079
small molecule | CAS: 1926203-09-9

Troriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).

Kategori:
Nervous System
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TT 173 DB17717
biotech

TT 173 is a Modified Human Tissue Factor currently being investigated to treat bleeding disorders such as hemophilia and von Willebrand disease, as well as bleeding episodes in cutaneous injuries or dental procedures.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TT-301 DB12899
small molecule | CAS: 886208-76-0

TT301 has been used in trials studying the treatment of Traumatic Brain Injury.

Target Protein:
Interleukin-1 beta
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TTX-MC138 DB18628
biotech

TTX-MC138 is an antisense oligonucleotide targeting miR-10b.[L48335] It is under investigation for the treatment of various metastatic cancers.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TTX-siPDL1 DB18550
biotech

TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TUM012 DB18652
biotech

TUM012 is a synthetic polymer PEG conjugated to a phospholipid anchor (2-dipalmitoyl-sn-glycerol-3-phosphatidylethanolamine)

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tuparstobart DB19118
biotech | CAS: 2649466-03-3

Tuparstobart is under investigation in clinical trial NCT05287113 (Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-line Treatment in Participants With Pd-l1-positive (CPS ? 1) Recurrent/metastatic Squamous Cell Carcinoma of the…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Turmeric Approved DB14276
biotech

Turmeric is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Kategori:
AngiospermsAntioxidantsBiological Factors +16
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 629664-81-9

Fxr 450 is under investigation in clinical trial NCT00509756 (Study Evaluating Turofexorate isopropyl in Healthy Japanese Men).

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Bile acid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 2254086-60-5

Tusamitamab ravtansine is an antibody-drug conjugate that targets carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5).

Kategori:
Amino Acids, Peptides, and ProteinsBlood ProteinsGlobulins +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tyramine DB08841
small molecule | CAS: 51-67-2

Tyramine (4-hydroxyphenethylamine; para-tyramine, mydrial or uteramin) is a naturally occurring monoamine compound and trace amine derived from the amino acid tyrosine. Tyramine acts by inducing the release of catecholamine. An important characteristic of thi…

Kategori:
Adrenergic AgentsAgents producing tachycardiaAgents that produce hypertension +9
Target Protein:
Trace amine-associated receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tyrosinase DB16626
biotech | CAS: 9002-10-2

Tyrosinase is a multi-copper-containing multifunctional metalloenzyme with 4 possible oxidation states.[A231829, A231834, A231839] It is responsible for producing melanin pigment across the phylogenetic spectrum.[A231829, A231834, A231839] Within mammals, …

Kategori:
Catechol OxidaseEnzymesEnzymes and Coenzymes +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tyrothricin Approved DB13503
small molecule | CAS: 1404-88-2

Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis [L4019, L4021, A32851] which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus [A36353]. This complex…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Bacterial AgentsAnti-Infective Agents +9
Target Protein:
Phospholipid membraneAcetylcholinesteraseBeta-galactosidase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
UB-612 DB16444
biotech

The UB-612 COVID-19 vaccine was developed by United Biomedical Inc Asia in Taipei as the first COVID-19 “multi-tope” protein-peptide vaccine made up of eight rationally designed components[L30653]. The vaccine incorporates a strong S1-RBD component linked to …

Kategori:
Biological ProductsComplex MixturesVaccines +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ublituximab Approved DB11850
biotech | CAS: 1174014-05-1

CD20, an antigen expressed by various B and T cells, is an attractive therapeutic target in various cancers and autoimmune conditions.[A244195, A244200, A244205] Monoclonal antibodies for B cell depletion rely on their binding affinity and ability to clear bo…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +11
Target Protein:
B-lymphocyte antigen CD20
Waktu ParuhThe estimated mean …
Vol. DistribusiThe estimated centr…
Klirens-
Genetik -
UK-390957 DB11719
small molecule | CAS: 934301-71-0

UK-390,957 has been used in trials studying the treatment of Ejaculation.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ularitide DB05034
small molecule | CAS: 118812-69-4

Ularitide is a synthetic form of urodilatin, a naturally occurring human natriuretic peptide that is involved in regulating blood pressure and the excretion of water and sodium from the kidneys. Urodilatin is produced in the kidney and excreted into the urine…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Asthmatic AgentsAutonomic Agents +10
Target Protein:
Atrial natriuretic peptide receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Uliledlimab DB16675
biotech | CAS: 2378407-27-1

Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ulipristal Approved DB08867
small molecule | CAS: 159811-51-5

Ulipristal is a selective progesterone receptor modulator used for the purposes of emergency contraception (Ella) and for the treatment of uterine fibroids (Fibristal). It is a derivative of 19-norprogesterone and has both antagonistic and partial agonist ac…

Kategori:
Adrenal Cortex HormonesContraceptive Agents, FemaleContraceptive Agents, Hormonal +16
Target Protein:
Progesterone receptorGlucocorticoid receptorAndrogen receptor
Waktu ParuhMean elimination ha…
Vol. Distribusi-
KlirensMean oral clearance…
Genetik -
Ulodesine DB12353
small molecule | CAS: 548486-59-5

Ulodesine has been used in trials studying the treatment of Gout, Arthritis, Hyperuricemia, and Joint Disease.

Kategori:
CarbohydratesIminesImino Sugars +3
Target Protein:
Purine nucleoside phosphorylase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ulviprubart DB18281
biotech | CAS: 2569434-60-0

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Unasnemab DB18837
biotech | CAS: 2379805-59-9

Unasnemab is under investigation in clinical trial NCT04683848 (Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Undecylenic acid Approved DB11117
small molecule | CAS: 112-38-9

Undecylenate, or undecylenic acid, is an unsaturated fatty acid with a terminal double bond that is derived from castor oil. Undecylenic acid is also found naturally in the human sweat. It is used as a precursor in the manufacture of aromatic chemicals, polym…

Kategori:
Antifungals for Dermatological UseAntifungals for Topical UseDermatologicals +4
Target Protein:
Calpain-1 catalytic subunit
Waktu ParuhNo information rega…
Vol. DistribusiNo information rega…
KlirensNo information rega…
Genetik -
Upadacitinib Approved DB15091
small molecule | CAS: 1310726-60-3

Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis to slow down disease progression. Rheumatoid arthritis is a chronic autoimmune inflammatory diseas…

Kategori:
Antineoplastic and Immunomodulating AgentsAntirheumatic AgentsBCRP/ABCG2 Inhibitors +16
Target Protein:
Tyrosine-protein kinase JAK1
Waktu ParuhThe mean terminal e…
Vol. DistribusiThe volume of distr…
KlirensThe apparent oral c…
Genetik -
biotech | CAS: 2254119-00-9

Upinitatug rilsodotin is under investigation in clinical trial NCT05329545 (Upifitamab Rilsodotin Maintenance in Platinum-sensitive Recurrent Ovarian Cancer (UP-NEXT)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Uracil C-13 DB16345
small molecule | CAS: 35803-45-3

Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Urethane Approved DB04827
small molecule | CAS: 51-79-6

Urethane, formerly marketed as an inactive ingredient in Profenil injection, was determined to be carcinogenic and was removed from the Canadian, US, and UK markets in 1963.

Kategori:
Acids, AcyclicAnestheticsAnesthetics, General +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Uric acid DB08844
small molecule | CAS: 69-93-2

Uric acid is the last product of purine metabolism in humans. The formation of uric acid is through the enzyme xanthine oxidase, which oxidizes oxypurines. Normally a small amount of uric acid is present in the body, but when there is an excess amount in the …

Kategori:
AlkaloidsAntioxidantsBiological Factors +6
Target Protein:
Glycogen phosphorylase, liver form
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Urofollitropin Approved DB00094
biotech | CAS: 97048-13-0

Urofollitropin is a urinary-derived follicle-stimulating hormone (FSH) that is extracted and purified from human urine samples. It consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and b…

Kategori:
Amino Acids, Peptides, and ProteinsGenito Urinary System and Sex HormonesGonadotropins +9
Target Protein:
Follicle-stimulating hormone receptor
Waktu ParuhCirculation half li…
Vol. DistribusiTime to peak in pla…
Klirens-
Genetik -
Urokinase Approved DB00013
biotech | CAS: 9039-53-6

Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase.[A191943] Urokinase remains connected between these 2 chains by a sulfhydryl bond.[A191943] Urokinase was granted …

Kategori:
Agents causing angioedemaAmino Acids, Peptides, and ProteinsAnticoagulants +15
Target Protein:
PlasminogenUrokinase plasminogen activator surface receptorPlasminogen activator inhibitor 1 +5
Waktu ParuhUrokinase has a hal…
Vol. DistribusiThe volume of distr…
KlirensData regarding the …
Genetik -
USL-311 DB15265
small molecule | CAS: 1373268-67-7

USL-311 is under investigation in clinical trial NCT02765165 (Phase 1/2 Study of USL311 Alone and in Combination With Lomustine in Subjects With Advanced Solid Tumors and Relapsed/Recurrent Glioblastoma Multiforme (GBM)).

Target Protein:
C-X-C chemokine receptor type 4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ustekinumab Approved DB05679
biotech | CAS: 815610-63-0

Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses.[A187349] It was generated via recombinant human IL-12 immunizati…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +16
Target Protein:
Interleukin-23Interleukin-12 subunit beta
Waktu ParuhFollowing administr…
Vol. DistribusiThe total volume of…
KlirensThe median apparent…
Genetik -
Uzansertib DB17571
small molecule | CAS: 2088852-47-3

Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With Advanced Malignancies).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
V116517 DB16060
small molecule | CAS: 1073616-61-1

V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)).

Kategori:
AminesPyridines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vaborbactam Approved DB12107
small molecule | CAS: 1360457-46-0

Vaborbactam is a ?-lactamase inhibitor based on a cyclic boronic acid pharmacophore.[A32053] It has been used in trials investigating the treatment of bacterial infections in subjects with varying degrees of renal insufficiency. In August 2017, a combination …

Kategori:
AcidsAcids, NoncarboxylicAnti-Infective Agents +6
Target Protein:
Beta-lactamaseBeta-lactamaseCarbapenem-hydrolyzing beta-lactamase KPC +7
Waktu ParuhThe half life of va…
Vol. DistribusiThe steady-state vo…
KlirensThe mean renal clea…
Genetik -
Vadadustat Approved DB12255
small molecule | CAS: 1000025-07-9

One of the most common symptoms of advanced renal disease is anemia, caused primarily by the inability of the kidney to respond to anemic conditions with a corresponding increase in [erythropoietin] (EPO) production.[A244165] The treatment of anemia associate…

Kategori:
Amino AcidsAmino Acids, Peptides, and ProteinsAntianemic Preparations +20
Target Protein:
Egl nine homolog 1Prolyl hydroxylase EGLN2Prolyl hydroxylase EGLN3 +2
Waktu ParuhIn patients with di…
Vol. DistribusiThe apparent volume…
KlirensIn healthy subjects…
Genetik -
Valaciclovir Approved DB00577
small molecule | CAS: 124832-26-4

Valaciclovir (valacyclovir), also known as _Valtrex_, is an antiviral drug that has been used to manage and treat various herpes infections for more than 2 decades. It was initially approved by the FDA in 1995 [FDA label] and marketed by GlaxoSmithKline [L56…

Kategori:
Acyclovir and prodrugAmino AcidsAmino Acids, Branched-Chain +19
Target Protein:
Thymidine kinaseDNA polymerase catalytic subunit
Waktu ParuhThe plasma eliminat…
Vol. DistribusiCerebrospinal fluid…
KlirensRenal clearance of …
Genetik -
Valerian Approved DB13196
biotech | CAS: 8057-49-6

Valerian is extracted from a herb that is a perennial flowering plant. Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is not completely understood. Valerian has been used in the treatment of conditions includ…

Kategori:
AngiospermsBiological ProductsCentral Nervous System Depressants +15
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 1034190-08-3

Valiltramiprosate is under investigation in clinical trial NCT06304883 (Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects).

Kategori:
AlkanesAlkanesulfonic AcidsAmino Acids +7
Target Protein:
Amyloid-beta precursor protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valproic acid Approved DB00313
small molecule | CAS: 99-66-1

Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a…

Kategori:
Acids, AcyclicAnti-epileptic AgentAnticonvulsants +68
Target Protein:
4-aminobutyrate aminotransferase, mitochondrialGlycogen synthase kinase-3 alphaHistone deacetylase 9 +13
Gen Terkait:
POLG POLG
Waktu Paruh13-19 hours.[label]…
Vol. Distribusi11 L/1.73m<sup>2</s…
Klirens0.56 L/hr/m<sup>2</…
Genetik 2 Varian
Vancomycin Approved DB00512
small molecule | CAS: 1404-90-6

Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. As of January 29 2018, CutisPharma's Firvanq is the only FDA approved vanc…

Kategori:
Agents that produce neuromuscular block (indirect)Alimentary Tract and MetabolismAmino Acids, Peptides, and Proteins +17
Target Protein:
D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan
Waktu ParuhHalf-life in normal…
Vol. DistribusiThe volume of distr…
KlirensThe mean plasma cle…
Genetik -
Vanillic acid DB02130
small molecule | CAS: 121-34-6

A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).

Kategori:
Acids, CarbocyclicBenzene DerivativesBenzoates +5
Target Protein:
Chorismate pyruvate-lyase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vardenafil Approved DB00862
small molecule | CAS: 224785-90-4

Vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) and an oral therapy for the treatment of erectile dysfunction.[L45563,L45568] During sexual stimulation, nitric oxide (NO) is released from n…

Kategori:
Cardiovascular AgentsCytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 CYP2C19 Inhibitors (weak) +30
Target Protein:
cGMP-specific 3',5'-cyclic phosphodiesteraseRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaRetinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
Waktu ParuhVardenafil and its …
Vol. DistribusiVardenafil has a st…
KlirensVardenafil has a to…
Genetik -
biotech

Recombinant zoster vaccine, manufactured as the product Shingrix by GlaxoSmithKline, is an adjuvanted non-live recombinant vaccine indicated for prevention of shingles. First approved in October 2017 by the Food and Drug Administration, Shingrix is the prefer…

Kategori:
VaccinesVaricella Zoster Vaccines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vayarin Approved DB09328
biotech

Vayarin is a prescription medical food for the clinical dietary management of certain lipid imbalances blamed to be associated with attention deficit hyperactivity disorder (ADHD) in children. Vayarin contains _Lipirinen_, a proprietary composition containing…

Kategori:
Cytochrome P-450 CYP2E1 InhibitorsCytochrome P-450 CYP2E1 Inhibitors (strength unknown)Cytochrome P-450 Enzyme Inhibitors
Waktu ParuhAbout 2h [L1507]
Vol. Distribusi-
KlirensMainly in the feces…
Genetik -
Veligrotug DB18976
biotech | CAS: 2728655-31-8

Veligrotug is under investigation in clinical trial NCT00791544 (Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 1851–1900 dari 1977
Sebelumnya Halaman 38 / 40 Berikutnya